This November, voters in three US states—Colorado, Washington, and Oregon—will be able to vote on ballot measures that would legalize marijuana, period.
Not just for medicinal purposes, but for recreational purposes, too.
At Rolling Stone, a smart blog post by Julian Brookes on what happens when the first state says "yes" to weed.
When that happens, expect one of two things – either: the federal government, in deference to democratic principles, will decline to enforce its ban on marijuana, creating space for the state to be a "laboratory of democracy," working out its new policy by trial and error, learning as it goes, creating a trove of hard-earned lessons to guide the states that (inevitably) will follow; or: the federal government will bide its time and then come down hard, busting growers and retailers, seizing land and property (or, just as effective, threatening to), going after banks that serve pot business, and doing whatever else it takes to shut down the state's legalization push.
True, the feds would be within their rights to crack down. A state can legalize all it wants, but – incredibly – happy-go-lucky marijuana will still be a Schedule I drug, right up there on the federal shit list with brain melters and organ fryers like Heroin, Cocaine, and PCP. And, no, this isn't some quaint, disregarded artifact from olden times: A personal stash can get you a year in federal prison, a single plant up to five.
Read the rest.
Jan Hoffman writes about recent research into the effects on psychedelics such as psilocybin on anxiety and depression: “About 80 percent of cancer patients showed clinically significant reductions in both psychological disorders, a response sustained some seven months after the single dose.” Dr. Jeffrey Lieberman, a past president of the American Psychiatric Association, and Dr. […]
The Telegraph created an interactive data visualization of cannabis use in countries around the world. Here are the winners: • Iceland – 16.2% (prevalence of use as percentage of population) • US – 16.2% • Nigeria – 14.3% • Canada – 12.7% • Chile – 11.83% • France – 11.1% • New Zealand – 11% […]
The smirking, villainous pharma-hedge-douche-bro Martin Shkreli (previously) bought the rights to the anti-parasitic drug Daraprim — used to treat malaria, a disease that disproportionately affects the poorest people in the world — and jacked the price from $13.50/dose to $750/dose.
The Pocket Tripod PRO had massive Kickstarter success in 2013, raising almost $85,000 in a single month. But this isn’t just another case of pre-release product hype.This ingenious little device folds out from a credit-card-shaped plastic slab into a sturdy stand with a surprisingly wide range of motion. In portrait orientation, your phone slides snugly […]
Loot Crate is a totally different kind of subscription service that mails subscribers monthly boxes filled with curated geek, pop culture, and gamer paraphernalia. Its cult following awaits a box every month filled with everything from bobble heads to T-shirts to special edition collectibles. But nothing gets Loot Crate fans as excited as the limited […]
The ARMOR-X Mini Flexible Phone Tripod is a smartphone tripod that is designed with flexible legs to rest on virtually any type of surface. Other tripods have proved useless unless I conveniently have a flat surface in front of me, which is why this particular tripod was appealing enough to try out. The ARMOR-X is compact and easy […]